Top Clinical Trials companies in Australia by Current Liabilities
Australia
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 4.95 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
| 2 |
USD 138.49 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
| 3 |
USD 107.20 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 4 |
USD 79.23 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
| 5 |
USD 73.24 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 6 |
USD 16.81 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
| 7 |
USD 15.50 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 8 |
USD 12.56 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
| 9 |
USD 9.42 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
| 10 |
USD 6.99 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Current Liabilities ?
The Clinical Trials company in Australia with the highest Current Liabilities is CSL Limited (ASX: CSL.AX) at USD 4.95 B.
-
Which Clinical Trials company in Australia has the lowest Current Liabilities ?
The Clinical Trials company in Australia with the lowest Current Liabilities is Immutep Limited (NasdaqGM: IMMP) at USD 6.99 M.
-
What are the top 10 Clinical Trials companies in Australia by Current Liabilities ?
The top 10 Clinical Trials companies in Australia by Current Liabilities are CSL Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, Monash IVF Group Limited, Mesoblast Limited, Clinuvel Pharmaceuticals Limited, PolyNovo Limited, Cogstate Limited, Anteris Technologies Ltd and Immutep Limited.
-
What are the bottom 10 Clinical Trials companies in Australia by Current Liabilities ?
The bottom 10 Clinical Trials companies in Australia by Current Liabilities are Immutep Limited, Anteris Technologies Ltd, Cogstate Limited, PolyNovo Limited, Clinuvel Pharmaceuticals Limited, Mesoblast Limited, Monash IVF Group Limited, Telix Pharmaceuticals Limited, Australian Clinical Labs Limited and CSL Limited.
